Clinical Trials Browser

Unknown × Neoplasm, Residual × Plasma cell × Clear all

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Phase 1 Unknown

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT05578625 2022-10-13

ctDNA Methylation Sequencing for Myeloma

Multiple Myeloma, Neoplasm, Residual

NCT05536700 2022-09-13

Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma

Multiple Myeloma, Neoplasm, Residual

NCT03702088 2019-11-19

Place of the Hevylite Test in the Evaluation of MRD in Myeloma

Neoplasm, Residual, Neoplasms, Plasma Cell

NCT04122092 2019-11-18

EUCADD

Multiple Myeloma, Neoplasm, Residual, Chromosomal Instability